A clear trend of increased enflicoxib and pyrazol metabolite plasma levels with increasing body weight was observed on days 44 and 189, being more evident for the pyrazol metabolite.
← all excerpts
Enflicoxib for the long-term management of canine osteoarthritis-External validation of a population pharmacokinetic model in dogs with osteoarthritis.
1
—
—